Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
K
KMS Medisurgi Ltd
Score 48/100• Risky
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health65/100
Valuation 20/100 · PB 5.1601
Technical Avoid
1M — 6M -0.315% 1Y -0.315%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#226
View details ➜
K
Kaya Ltd
Score 48/100• Risky
Kaya Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health43/100
Valuation 100/100 · PB -3.875
Technical Avoid
1M -14.711% 6M 3.702% 1Y -3.838%
Confidence100%
No promoter pledgeHealthy profit margins
#227
View details ➜
H
Hamps Bio Ltd
Score 48/100• Risky
Hamps Bio Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
Company’s Health81/100
Valuation 60/100 · PB 2.1453
Technical Avoid
1M -6.898% 6M 1.976% 1Y -57.401%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#228
View details ➜
H
Haleos Labs Ltd
Score 48/100• Risky
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health70/100
Valuation 80/100 · PB 1.6849
Technical Avoid
1M 3.985% 6M -12.917% 1Y -13.995%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#229
View details ➜
G
Gian Life Care Ltd
Score 48/100• Risky
Gian Life Care Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability metrics.
Company’s Health37/100
Valuation 100/100 · PB 0.4679
Technical Avoid
1M -31.141% 6M -41.357% 1Y -55.583%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#230
View details ➜
D
Desh Rakshak Aushdhalaya Ltd
Score 48/100• Risky
Desh Rakshak Aushdhalaya Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
Company’s Health62/100
Valuation 80/100 · PB 1.934
Technical Avoid
1M -0.207% 6M -11.342% 1Y 113.87%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#231
View details ➜
C
Cian Healthcare Ltd
Score 48/100• Decent
Cian Healthcare Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health13/100
Valuation 100/100 · PB 0.4094
Technical Avoid
1M -23.836% 6M 30.864% 1Y 11.579%
Confidence100%
Reasonable PB valuation
Weak ROEHigh debt/equity
#232
View details ➜
B
Bliss GVS Pharma Ltd
Score 48/100• Decent
Bliss GVS Pharma Ltd shows potential but faces challenges in profitability and execution risks. Investors should proceed with caution.
Company’s Health61/100
Valuation 80/100 · PB 1.3988
Technical Avoid
1M -4.695% 6M -2.735% 1Y -16.9%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#233
View details ➜
A
Ambey Laboratories Ltd
Score 48/100• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health77/100
Valuation 80/100 · PB 1.307
Technical Avoid
1M 6.667% 6M -1.84% 1Y -43.543%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#234
View details ➜
A
Amanta Healthcare Ltd
Score 48/100• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
Company’s Health58/100
Valuation 40/100 · PB 3.8062
Technical Avoid
1M -14.749% 6M -25.503% 1Y -25.503%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#235
View details ➜
A
Adeshwar Meditex Ltd
Score 48/100• Risky
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health64/100
Valuation 100/100 · PB 0.6634
Technical Avoid
1M 4.492% 6M -6.904% 1Y -26.13%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#236
View details ➜
A
Amwill Health Care Ltd
Score 48/100• Risky
Amwill Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health98/100
Valuation 80/100 · PB 1.0847
Technical Avoid
1M -25.415% 6M -46.667% 1Y -59.678%
Confidence100%
Low leverage (D/E)No promoter pledge
#237
View details ➜
A
Alivus Life Sciences Ltd
Score 48/100• Risky
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health93/100
Valuation 40/100 · PB 3.8696
Technical Avoid
1M -3.143% 6M -13.623% 1Y -14.252%
Confidence100%
Low leverage (D/E)No promoter pledge
#238
View details ➜
A
Albert David Ltd
Score 48/100• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
Company’s Health66/100
Valuation 80/100 · PB 1.1201
Technical Avoid
1M -12.059% 6M -10.493% 1Y -46.537%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#239
View details ➜
G
Godavari Drugs Ltd
Score 48/100• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
Company’s Health52/100
Valuation 80/100 · PB 1.2401
Technical Avoid
1M -8.276% 6M -24.723% 1Y -42.191%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#240
View details ➜
Showing 226 to 240 of 260 (18 Pages)